The concordance rate between cfDNA and tumor DNA was 16.5% (21 of 127 mutations) after excluding genes associated with CHIP (Fig. 1e), suggesting that cfDNA identifies possible relevant GAs that are not captured by single-lesion tumor biopsy. The gene discussed is STUB1; the disease is neoplasm.